City Financial Investment Company’s Syneron Medical Ltd ELOS Stock Holding History

City Financial Investment Company’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-399,948	Closed	-$4.38M	–	111
2017 Q2	$4.38M	Buy	+399,948	New	+$4.39M	0.48%	55

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return

City Financial Investment Company's ELOS Position: Q3 2017 in Review

City Financial Investment Company sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 399,948 shares — an estimated $4.38M sold.

City Financial Investment Company first reported a position in ELOS in Q2 2017 and held it in 1 quarter. The position peaked at $4.38M in Q2 2017. 3 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

City Financial Investment Company reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
City Financial Investment Company sold 399,948 Syneron Medical Ltd shares in Q3 2017, an estimated $4.38M.
City Financial Investment Company first reported a position in Syneron Medical Ltd in Q2 2017 and held it in 1 quarter.
City Financial Investment Company's Syneron Medical Ltd position peaked at $4.38M in Q2 2017.
3 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on City Financial Investment Company's 13F filing for Q3 2017, filed 14 Nov 2017.